This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Rao, C. V. Articles by Reddy, B. S. Search for Related Content PubMed PubMed Citation Articles by Rao, C. V. Articles by Reddy, B. S.

Enhancement of Experimental Colon Cancer by Genistein¹

Divisions of Nutritional Carcinogenesis [C. V. R., B. S., B. S. R.] and Pathology [C-X. W.], American Health Foundation, Valhalla, New York 10595; and Division of Cancer Control and Prevention, Chemoprevention Branch, National Cancer Institute, Bethesda, Maryland 20892 [R. L., V. S., G. K.]

Several phytochemicals and micronutrients that are present in fruits and vegetables are known to exert cancer chemopreventive effects in several organs, including the colon. Among them, the soybean isoflavonoid genistein received much attention due to its potential anticarcinogenic, antiproliferative effects and its potential role in several signal transduction pathways. The present study was designed to investigate the effect of genistein on azoxymethane (AOM)-induced colon carcinogenesis and to study its modulatory role on the levels of activity of 8-isoprostane, cyclooxygenase (COX), and 15-hydroxyprostaglandin F₂ dehydrogenase (15-PGDH) in the colonic mucosa and colon tumors of male F344 rats. At 5 weeks of age, groups of male F344 rats were fed control (AIN-76A) diet or a diet containing 250 ppm genistein. Beginning 2 weeks later, all animals except those in the vehicle-treated groups were given weekly s.c. injections of AOM (15 mg/kg body weight) for 2 successive weeks. All rats were continued on their respective dietary regimen for 52 weeks after AOM treatment and were then sacrificed. Colon tumors were evaluated histopathologically. Colonic mucosae and tumors were analyzed for COX, 15-PGDH, and 8-isoprostane levels. Administration of genistein significantly increased noninvasive and total adenocarcinoma multiplicity (P < 0.01) in the colon, compared to the control diet, but it had no effect on the colon adenocarcinoma incidence nor on the multiplicity of invasive adenocarcinoma (P > 0.05). Also, genistein signifciantly inhibited the 15-PGDH activity (>35%) and levels of 8-isooprostane (50%) in colonic mucosa and in tumors. In contrast, genistein had no significant effect on the COX synthetic activity, as measured by the rate of formation of prostaglandins and thromboxane B₂ from [¹⁴C]arachidonic acid. The results of this investigation emphasize that the biological effects of genistein may be organ specific, inhibiting cancer development in some sites yet showing no effect or an enhancing effect on the tumorigenesis at other sites, such as the colon. The inhibition of 8-isoprostane levels by genistein indicates its possible antioxidant potential, which is independent of the observed colon tumor enhancement, yet this agent may also possess several biological effects that overshadow its antioxidant potential. The exact mechanism(s) of colon tumor enhancement by genistein remain to be elucidated; it is likely that its colon tumor-enhancing effects may, at least in part, be related to inhibition of prostaglandin catabolic enzyme activities.

¹ This work was supported in part by United States Public Health Service Grants CA17613 and NO1CN-25450-01 from the National Cancer Institute.

² To whom requests for reprints should be addressed.

Received 4/15/97. Accepted 7/ 3/97.

This article has been cited by other articles:

				J. Bhatia, F. Greer, and and the Committee on Nutrition Use of Soy Protein-Based Formulas in Infant Feeding Pediatrics, May 1, 2008; 121(5): 1062 - 1068. [Abstract] [Full Text] [PDF]

				Y.-M. Cho, T. Imai, Y. Ota, M. Hasumura, S. Takami, M. Hirose, and A. Nishikawa A New Medium-term Rat Colorectal Bioassay Applying Neoplastic Lesions as End Points for Detection of Carcinogenesis Modifiers Effects with Weak or Controversial Modifiers Toxicol Pathol, April 1, 2008; 36(3): 459 - 464. [Abstract] [Full Text] [PDF]

				R. Wang, W.M. Dashwood, C. V. Lohr, K. A. Fischer, C. B. Pereira, M. Louderback, H. Nakagama, G. S. Bailey, D. E. Williams, and R. H. Dashwood Protective versus promotional effects of white tea and caffeine on PhIP-induced tumorigenesis and {beta}-catenin expression in the rat Carcinogenesis, April 1, 2008; 29(4): 834 - 839. [Abstract] [Full Text] [PDF]

				A. Fichera, N. Little, S. Jagadeeswaran, U. Dougherty, A. Sehdev, R. Mustafi, S. Cerda, W. Yuan, S. Khare, M. Tretiakova, et al. Epidermal Growth Factor Receptor Signaling Is Required for Microadenoma Formation in the Mouse Azoxymethane Model of Colonic Carcinogenesis Cancer Res., January 15, 2007; 67(2): 827 - 835. [Abstract] [Full Text] [PDF]

				M. G. Manjanatha, S. Shelton, M. E. Bishop, L. E. Lyn-Cook, and A. Aidoo Dietary effects of soy isoflavones daidzein and genistein on 7,12-dimethylbenz[a]anthracene-induced mammary mutagenesis and carcinogenesis in ovariectomized Big Blue(R) transgenic rats. Carcinogenesis, December 1, 2006; 27(12): 2555 - 2564. [Abstract] [Full Text] [PDF]

				M. Manjanatha, S. Shelton, M. Bishop, L. Lyn-Cook, and A. Aidoo Dietary effects of soy isoflavones daidzein and genistein on 7,12-dimethylbenz[a]anthracene-induced mammary mutagenesis and carcinogenesis in ovariectomized Big Blue transgenic rats Carcinogenesis, October 1, 2006; 27(10): 1970 - 1979. [Abstract] [Full Text] [PDF]

				A. Y.A. Plate and D. D. Gallaher Effects of Indole-3-Carbinol and phenethyl isothiocyanate on colon carcinogenesis induced by azoxymethane in rats Carcinogenesis, February 1, 2006; 27(2): 287 - 292. [Abstract] [Full Text] [PDF]

				R. S. MacDonald, J. Guo, J. Copeland, J. D. Browning Jr, D. Sleper, G. E. Rottinghaus, and M. A. Berhow Environmental Influences on Isoflavones and Saponins in Soybeans and Their Role in Colon Cancer J. Nutr., May 1, 2005; 135(5): 1239 - 1242. [Abstract] [Full Text] [PDF]

				M. G. Backlund, J. R. Mann, V. R. Holla, F. G. Buchanan, H.-H. Tai, E. S. Musiek, G. L. Milne, S. Katkuri, and R. N. DuBois 15-Hydroxyprostaglandin Dehydrogenase Is Down-regulated in Colorectal Cancer J. Biol. Chem., February 4, 2005; 280(5): 3217 - 3223. [Abstract] [Full Text] [PDF]

				V. Quidville, N. Segond, E. Pidoux, R. Cohen, A. Jullienne, and S. Lausson Tumor Growth Inhibition by Indomethacin in a Mouse Model of Human Medullary Thyroid Cancer: Implication of Cyclooxygenases and 15-Hydroxyprostaglandin Dehydrogenase Endocrinology, May 1, 2004; 145(5): 2561 - 2571. [Abstract] [Full Text] [PDF]

				T. J. Jerde, W. S. Mellon, S. M. Fischer, M. Liebert, D. E. Bjorling, and S. Y. Nakada Suppression of 15-Hydroxyprostaglandin Dehydrogenase Messenger RNA Concentration, Protein Expression, and Enzymatic Activity during Human Ureteral Obstruction J. Pharmacol. Exp. Ther., April 1, 2004; 309(1): 398 - 403. [Abstract] [Full Text]

				A. Hikosaka, M. Asamoto, N. Hokaiwado, K. Kato, K. Kuzutani, K. Kohri, and T. Shirai Inhibitory effects of soy isoflavones on rat prostate carcinogenesis induced by 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP) Carcinogenesis, March 1, 2004; 25(3): 381 - 387. [Abstract] [Full Text] [PDF]

				J.-Y. Guo, X. Li, J. D. Browning Jr., G. E. Rottinghaus, D. B. Lubahn, A. Constantinou, M. Bennink, and R. S. MacDonald Dietary Soy Isoflavones and Estrone Protect Ovariectomized ER{alpha}KO and Wild-Type Mice from Carcinogen-Induced Colon Cancer J. Nutr., January 1, 2004; 134(1): 179 - 182. [Abstract] [Full Text] [PDF]

				M. Ochiai, M. Ushigome, K. Fujiwara, T. Ubagai, T. Kawamori, T. Sugimura, M. Nagao, and H. Nakagama Characterization of Dysplastic Aberrant Crypt Foci in the Rat Colon Induced by 2-Amino-1-Methyl-6-Phenylimidazo[4,5-b]Pyridine Am. J. Pathol., October 1, 2003; 163(4): 1607 - 1614. [Abstract] [Full Text] [PDF]

				H. Tsuda, A. Naito, C. K. Kim, K. Fukamachi, H. Nomoto, and M. A. Moore Carcinogenesis and Its Modification by Environmental Endocrine Disruptors: In Vivo Experimental and Epidemiological Findings Jpn. J. Clin. Oncol., June 1, 2003; 33(6): 259 - 270. [Abstract] [Full Text] [PDF]

				Y. Yamada and H. Mori Pre-cancerous lesions for colorectal cancers in rodents: a new concept Carcinogenesis, June 1, 2003; 24(6): 1015 - 1019. [Abstract] [Full Text] [PDF]

				Y. Hirose, T. Kuno, Y. Yamada, K. Sakata, M. Katayama, K. Yoshida, Z. Qiao, K. Hata, N. Yoshimi, and H. Mori Azoxymethane-induced beta-catenin-accumulated crypts in colonic mucosa of rodents as an intermediate biomarker for colon carcinogenesis Carcinogenesis, January 1, 2003; 24(1): 107 - 111. [Abstract] [Full Text] [PDF]

				C.-L. Sun, J.-M. Yuan, K. Arakawa, S.-H. Low, H.-P. Lee, and M. C. Yu Dietary Soy and Increased Risk of Bladder Cancer: the Singapore Chinese Health Study Cancer Epidemiol. Biomarkers Prev., December 1, 2002; 11(12): 1674 - 1677. [Abstract] [Full Text] [PDF]

				K. R. Kozak, B. C. Crews, J. D. Morrow, L.-H. Wang, Y. H. Ma, R. Weinander, P.-J. Jakobsson, and L. J. Marnett Metabolism of the Endocannabinoids, 2-Arachidonylglycerol and Anandamide, into Prostaglandin, Thromboxane, and Prostacyclin Glycerol Esters and Ethanolamides J. Biol. Chem., November 15, 2002; 277(47): 44877 - 44885. [Abstract] [Full Text] [PDF]

				L. J. Coleman, E. K. Landstrom, P. J. Royle, A. R. Bird, and G. H. McIntosh A Diet Containing {alpha}-Cellulose and Fish Oil Reduces Aberrant Crypt Foci Formation and Modulates Other Possible Markers for Colon Cancer Risk in Azoxymethane-Treated Rats J. Nutr., August 1, 2002; 132(8): 2312 - 2318. [Abstract] [Full Text] [PDF]

				C. D. Davis and W. T. Johnson Dietary Copper Affects Azoxymethane-Induced Intestinal Tumor Formation and Protein Kinase C Isozyme Protein and mRNA Expression in Colon of Rats J. Nutr., May 1, 2002; 132(5): 1018 - 1025. [Abstract] [Full Text] [PDF]

				R. Hakkak, S. Korourian, M. J. J. Ronis, J. M. Johnston, and T. M. Badger Dietary Whey Protein Protects against Azoxymethane-induced Colon Tumors in Male Rats Cancer Epidemiol. Biomarkers Prev., May 1, 2001; 10(5): 555 - 558. [Abstract] [Full Text]

				Y. Yamada, N. Yoshimi, Y. Hirose, K. Matsunaga, M. Katayama, K. Sakata, M. Shimizu, T. Kuno, and H. Mori Sequential Analysis of Morphological and Biological Properties of {beta}-Catenin-accumulated Crypts, Provable Premalignant Lesions Independent of Aberrant Crypt Foci in Rat Colon Carcinogenesis Cancer Res., March 1, 2001; 61(5): 1874 - 1878. [Abstract] [Full Text]

				J.M. Gee, H.P.J.M. Noteborn, A.C.J. Polley, and I.T. Johnson Increased induction of aberrant crypt foci by 1,2-dimethylhydrazine in rats fed diets containing purified genistein or genistein-rich soya protein Carcinogenesis, December 1, 2000; 21(12): 2255 - 2259. [Abstract] [Full Text] [PDF]

				H.-M. Lin, B.-K. Moon, F. Yu, and H.-R. C. Kim Galectin-3 mediates genistein-induced G2/M arrest and inhibits apoptosis Carcinogenesis, November 1, 2000; 21(11): 1941 - 1945. [Abstract] [Full Text] [PDF]

				C. Nagata Ecological study of the association between soy product intake and mortality from cancer and heart disease in Japan Int. J. Epidemiol., October 1, 2000; 29(5): 832 - 836. [Abstract] [Full Text] [PDF]

				J. Yamakoshi, M. K. Piskula, T. Izumi, K. Tobe, M. Saito, S. Kataoka, A. Obata, and M. Kikuchi Isoflavone Aglycone-Rich Extract without Soy Protein Attenuates Atherosclerosis Development in Cholesterol-Fed Rabbits J. Nutr., August 1, 2000; 130(8): 1887 - 1893. [Abstract] [Full Text]

				W. W. and C. M. Higuchi Dietary Soy Protein Is Associated with Reduced Intestinal Mucosal Polyamine Concentration in Male Wistar Rats J. Nutr., July 1, 2000; 130(7): 1815 - 1820. [Abstract] [Full Text]

				B. L. Pool-Zobel, H. Adlercreutz, M. Glei, U. M. Liegibel, J. Sittlingon, I. Rowland, K. Wahala, and G. Rechkemmer Isoflavonoids and lignans have different potentials to modulate oxidative genetic damage in human colon cells Carcinogenesis, June 1, 2000; 21(6): 1247 - 1252. [Abstract] [Full Text] [PDF]

				T. Sugimura Nutrition and dietary carcinogens Carcinogenesis, March 1, 2000; 21(3): 387 - 395. [Abstract] [Full Text] [PDF]

				M. J. Weyant, A. M. Carothers, M. E. Bertagnolli, and M. M. Bertagnolli Colon Cancer Chemopreventive Drugs Modulate Integrin-mediated Signaling Pathways Clin. Cancer Res., March 1, 2000; 6(3): 949 - 956. [Abstract] [Full Text]

				J.-R. Zhou, E. T. Gugger, T. Tanaka, Y. Guo, G. L. Blackburn, and S. K. Clinton Soybean Phytochemicals Inhibit the Growth of Transplantable Human Prostate Carcinoma and Tumor Angiogenesis in Mice J. Nutr., September 1, 1999; 129(9): 1628 - 1635. [Abstract] [Full Text]

				M. J. Davies, E. A. Bowey, H. Adlercreutz, I. R. Rowland, and P. C. Rumsby Effects of soy or rye supplementation of high-fat diets on colon tumour development in azoxymethane-treated rats Carcinogenesis, June 1, 1999; 20(6): 927 - 931. [Abstract] [Full Text] [PDF]

				Y. Zhang, T. T. Song, J. E. Cunnick, P. A. Murphy, and S. Hendrich Daidzein and Genistein Glucuronides In Vitro Are Weakly Estrogenic and Activate Human Natural Killer Cells at Nutritionally Relevant Concentrations J. Nutr., February 1, 1999; 129(2): 399 - 405. [Abstract] [Full Text] [PDF]